
AgeX Therapeutics AGE
AgeX Therapeutics ROCE | AGE
ROCE Jährlich AgeX Therapeutics
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -709.03 | -379.6 | 10.85 | 103.58 | 137.49 | 876.74 | -302.99 | -136.62 | - | 77.56 | - | - | - | - | - |
Jährliche Entwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 876.74 | -709.03 | -35.78 |
ROCE Vierteljährlich AgeX Therapeutics
| 2026-Q3 | 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -435.67 | -493.79 | -463.02 | -596.8 | -540.92 | -277.16 | 27.11 | 169.39 | 295.89 | 212.98 | 15.9 | 11.08 | 18.44 | 36.75 | 57.46 | 81.57 | 107.16 | 124.5 | 180.81 | 437.42 | 567.8 | 895.87 | -4566.72 | -4048.98 | -4277.01 | -4707.36 | 629.34 | -313.55 | -277.6 | -244.11 | -246.67 | -105.91 | -29.57 | -28.66 | -47.68 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Quartalsentwicklung
Kennzahlen zur Anzeige auswählen
Alle Zahlen in USD-Währung
Indikatorspanne aus vierteljährlicher Berichterstattung
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 895.87 | -4707.36 | -509.48 |
ROCE anderer Aktien in der Pharmaeinzelhändler
| Name | ROCE | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Allena Pharmaceuticals
ALNA
|
-53.64 | - | 3.16 % | $ 1.9 M | ||
|
Adaptimmune Therapeutics plc
ADAP
|
-37.9 | - | -15.15 % | $ 60.3 M | ||
|
TFF Pharmaceuticals
TFFP
|
-228.86 | - | -60.05 % | $ 125 K | ||
|
Codiak BioSciences
CDAK
|
-48.13 | - | -55.98 % | $ 2.15 M | ||
|
Sage Therapeutics
SAGE
|
-90.91 | - | - | $ 527 M | ||
|
Paratek Pharmaceuticals
PRTK
|
27.02 | - | - | $ 121 M | ||
|
AVEO Pharmaceuticals
AVEO
|
-7.11 | - | - | $ 521 M | ||
|
Cyclerion Therapeutics
CYCN
|
-47.25 | $ 34.99 | 3.77 % | $ 147 M | ||
|
Seelos Therapeutics
SEEL
|
120.86 | - | -47.76 % | $ 6.27 M | ||
|
Завод ДИОД
DIOD
|
5.84 | - | - | - | ||
|
Kiromic BioPharma
KRBP
|
192.36 | - | 6.61 % | $ 3.08 M | ||
|
Deciphera Pharmaceuticals
DCPH
|
-60.12 | - | - | $ 2.18 B | ||
|
Fusion Pharmaceuticals
FUSN
|
-44.6 | - | - | $ 1.41 B | ||
|
Gritstone Oncology
GRTS
|
-269.28 | - | 0.42 % | $ 213 M | ||
|
Aridis Pharmaceuticals
ARDS
|
123.77 | - | 17.91 % | $ 11.1 M | ||
|
Titan Pharmaceuticals
TTNP
|
-186.76 | - | -3.76 % | $ 3.47 M | ||
|
HOOKIPA Pharma
HOOK
|
-88.88 | - | -6.92 % | $ 79.4 M | ||
|
Otonomy
OTIC
|
-90.38 | - | -1.96 % | $ 4.68 M | ||
|
Ligand Pharmaceuticals Incorporated
LGND
|
2.69 | $ 286.96 | 0.01 % | $ 5.55 B | ||
|
Фармсинтез
LIFE
|
-4.03 | - | - | - | ||
|
Actinium Pharmaceuticals
ATNM
|
-82.74 | $ 1.04 | -4.59 % | $ 32.4 M | ||
|
Oncternal Therapeutics
ONCT
|
-138.81 | - | -24.12 % | $ 1.56 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
-60.13 | - | - | $ 26.5 M | ||
|
Concert Pharmaceuticals
CNCE
|
-69.06 | - | - | $ 401 M | ||
|
Histogen
HSTO
|
-56.41 | - | 31.6 % | $ 2.12 M | ||
|
Checkpoint Therapeutics
CKPT
|
444.94 | - | - | $ 169 M | ||
|
Clovis Oncology
CLVS
|
-15.16 | - | -7.23 % | $ 13 M | ||
|
Taro Pharmaceutical Industries Ltd.
TARO
|
1.01 | - | - | $ 1.62 B | ||
|
Omeros Corporation
OMER
|
101.29 | $ 13.23 | -5.71 % | $ 840 M | ||
|
BioLineRx Ltd.
BLRX
|
-35.74 | $ 0.94 | -10.44 % | $ 2.32 B | ||
|
PhaseBio Pharmaceuticals
PHAS
|
115.4 | - | 7.4 % | $ 6.29 M | ||
|
Forma Therapeutics Holdings
FMTX
|
-34.91 | - | - | $ 958 M | ||
|
Blueprint Medicines Corporation
BPMC
|
-60.1 | - | - | $ 8.14 B | ||
|
Horizon Therapeutics Public Limited Company
HZNP
|
7.56 | - | - | $ 26.6 B | ||
|
Provention Bio
PRVB
|
-87.5 | - | - | $ 2.37 B | ||
|
Reata Pharmaceuticals
RETA
|
-58.16 | - | - | $ 6.29 B | ||
|
PainReform Ltd.
PRFX
|
-58.14 | $ 0.47 | -24.53 % | $ 305 K | ||
|
iTeos Therapeutics
ITOS
|
-27.03 | - | - | $ 411 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
-146.69 | $ 1.44 | -2.03 % | $ 2.37 M | ||
|
PolarityTE
PTE
|
-134.63 | - | -0.82 % | $ 1.78 M | ||
|
Kronos Bio
KRON
|
-106.06 | - | 1.49 % | $ 50.8 M | ||
|
Cullinan Management
CGEM
|
-58.85 | $ 8.9 | -1.93 % | $ 536 M | ||
|
CRISPR Therapeutics AG
CRSP
|
-31.41 | $ 39.15 | 0.57 % | $ 3.52 B | ||
|
Advaxis
ADXS
|
429.74 | - | -9.65 % | $ 45.9 M | ||
|
Stoke Therapeutics
STOK
|
-5.71 | $ 26.77 | -0.59 % | $ 1.59 B | ||
|
Trevena
TRVN
|
-106.77 | - | -46.58 % | $ 31.8 M | ||
|
Calithera Biosciences
CALA
|
-206.33 | - | -10.95 % | $ 876 K | ||
|
Molecular Templates
MTEM
|
-57.94 | - | -23.43 % | $ 495 K | ||
|
Oncorus
ONCR
|
-126.46 | - | -8.54 % | $ 3.19 M | ||
|
BioXcel Therapeutics
BTAI
|
52.86 | $ 0.07 | 9.81 % | $ 855 K |